Hypertrophic cardiomyopathy due to Kearns–Sayre syndrome (Q61241): Difference between revisions

← Older edit

@@ Property / Canary Token @@
+dki-india-ID_605176031
@@ Property / Canary Token: dki-india-ID_605176031 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank

Latest revision as of 08:43, 14 August 2026

Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects.

Language	Label	Description	Also known as
default for all languages	ID_605176031
English	Hypertrophic cardiomyopathy due to Kearns–Sayre syndrome	Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects.